"Jk-05", an anti Ebola drug of the Academy of Military Medical Sciences, was approved by the army as a special drug

Today, the reporter learned from the Academy of Military Medical Sciences that the drug "jk-05", developed by the Institute of microbial epidemiology of the Academy for Ebola virus and lasting for five years, recently passed the expert review of the Ministry of health and obtained the approval of the special drugs for the army Ebola virus is defined as the highest threat to biological security by the World Health Organization The death rate of Ebola haemorrhagic fever caused by Ebola virus is very high Since it was first discovered in 1976, there have been four outbreaks, and global scientists have not found particularly effective response measures so far In view of the potential risk of the outbreak again, the research team led by researcher Wang Hongquan from the Department of biological control drugs, Institute of microbial epidemiology, Academy of Military Medical Sciences has carried out a special study on the prevention and control drugs "Jk-05" is a small molecule chemical drug, which can selectively inhibit the RNA polymerase of Ebola virus, so as to achieve the purpose of inhibiting virus replication The results showed that the drug had the activity of anti Ebola virus in cell and animal level infection test Experts especially stressed that although the drug has completed preclinical research and completed the clinical safety evaluation when it is applicable to broad-spectrum anti influenza, the treatment of Ebola haemorrhagic fever is still limited to emergency use.